---
$id: https://graph.org.ai/products/commodity/51282303
$type: Product
source: UNSPSC
code: "51282303"
title: "Dirithromycin"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dirithromycin

**UNSPSC Code**: 51282303
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic with the molecular formula C42H78N2O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1801D76STL, chemically known as erythromycin, 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethylidene)oxy)-, (9s(r))- but generally known as dirithromycin, which bears US NIH Compound Identifier 5464388. European Medicines Agency schedules Dirithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07232MIG. The term DIRITHROMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules dirithromycin in its Anatomical Therapeutic Chemical (ATC) Classification. DIRITHROMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dirithromycin under HS 29415000 and SITC 54139. As of Q4 2014, DIRITHROMYCIN remains the US FDA Preferred Term for this commodity. Dirithromycin bears US NLM identifiers UMLS ID C0058445 and NCI Concept Code C47496. SMILES: O1C2C(C(NC1COCCOC)C(CC(O)(C(OC1OC(CC(N(C)C)C1O)C)C(C(OC1OC(C(O)C(OC)(C1)C)C)C(C(=O)OC(C2(O)C)CC)C)C)C)C)C.

